Ophthalmic compositions containing combinations of a carbonic anhydrase inhibitor and a beta adrenergic antagonist.

摘要

Combinations of a beta -adrenergic antagonist and a topical carbonic anhydrase inhibitor are particularly useful in the treatment of ocular hypertension, especially in patients insufficiently responsive to treatment with beta -adrenergic antagonists. IMAGE